Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Revance Therapeutics, Inc. | 96,407 | reported | 15 Oct 2018 | tx 5+187,250−7,093 |
| NovaBay Pharmaceuticals, Inc. | 20,000 | reported | 30 May 2019 | tx 6+77,002 |
| Zeltiq Aesthetics Inc | 0 | reported | 28 Apr 2017 | tx 6+124,460−124,460 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 May 2019 | GRANT_AWARD | NovaBay Pharmaceuticals, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Oct 2018 | TAX_WITHHOLDING | Revance Therapeutics, Inc. | 7,093 | 23.94 USD | |
| 31 May 2018 | GRANT_AWARD | NovaBay Pharmaceuticals, Inc. | 20,000 | 0.00 USD | deriv |
| 08 Feb 2018 | GRANT_AWARD | Revance Therapeutics, Inc. | 8,500 | 0.00 USD | |
| 08 Feb 2018 | GRANT_AWARD | Revance Therapeutics, Inc. | 48,750 | 0.00 USD | deriv |
| 18 Sept 2017 | GRANT_AWARD | Revance Therapeutics, Inc. | 95,000 | 0.00 USD | |
| 18 Sept 2017 | GRANT_AWARD | Revance Therapeutics, Inc. | 35,000 | 0.00 USD | deriv |
| 28 Apr 2017 | OTHER | Zeltiq Aesthetics Inc | 99,971 | — | |
| 28 Apr 2017 | OTHER | Zeltiq Aesthetics Inc | 16,674 | 0.00 USD | deriv |
| 24 Feb 2017 | TAX_WITHHOLDING | Zeltiq Aesthetics Inc | 7,815 | 55.62 USD | |
| 18 Jan 2017 | GRANT_AWARD | Zeltiq Aesthetics Inc | 8,737 | 0.00 USD | |
| 18 Jan 2017 | GRANT_AWARD | Zeltiq Aesthetics Inc | 16,674 | 0.00 USD | deriv |
| 03 Jan 2017 | GRANT_AWARD | NovaBay Pharmaceuticals, Inc. | 22,359 | 0.00 USD | deriv |
| 03 Oct 2016 | GRANT_AWARD | NovaBay Pharmaceuticals, Inc. | 3,303 | 0.00 USD | deriv |
| 01 Jul 2016 | GRANT_AWARD | NovaBay Pharmaceuticals, Inc. | 11,093 | 0.00 USD | deriv |
| 01 Feb 2016 | GRANT_AWARD | Zeltiq Aesthetics Inc | 99,049 | 0.00 USD |